Related Experiment Videos
Expression microarray analysis of brain tumors: what have we learned so far.
Stephen B Hunter1, Carlos S Moreno
1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30087, USA. Stephen_Hunter@Emory.org
Frontiers in Bioscience : a Journal and Virtual Library
|July 23, 2002
Summary
Expression microarray technology aids in understanding human brain tumors. This method distinguishes tumor types and identifies key genes involved in their development and prognosis.
Area of Science:
- Neuroscience
- Genomics
- Oncology
Background:
- Expression microarray technology is an emerging tool in human brain tumor research.
- Understanding gene expression patterns is crucial for diagnosing and treating brain tumors.
Purpose of the Study:
- To review the application of expression microarray technology in human brain tumors.
- To highlight the capabilities and challenges of this technology in neuro-oncology.
Main Methods:
- Description and contrast of dual and single color microarray techniques.
- Emphasis on proper handling of biological samples.
- Review of data interpretation and cluster analysis approaches.
Main Results:
- Microarrays have successfully differentiated prognostic groups within medulloblastomas.
- Distinction between medulloblastomas and supratentorial primitive neuroectodermal tumors (PNETs) was achieved.
- Confirmation of differential expression for known brain tumor pathogenesis genes (e.g., EGFR, VEGF).
- Identification of novel gene roles (e.g., insulin growth factor binding protein 2, apolipoprotein D).
Conclusions:
- Expression microarrays show significant potential in classifying brain tumors and identifying prognostic markers.
- The technology has confirmed known gene involvement and revealed new candidate genes in brain tumor development.
- Further research using expression microarrays is warranted to advance neuro-oncology.